SAGE Therapeutics Investors
SAGE Therapeutics is a prominent accelerator and incubator located in Cambridge, Massachusetts, established in 2010 The organization focuses on advancing innovative therapies for central nervous system disorders With a significant investment scale of $90,000,000, SAGE Therapeutics is dedicated to fostering the development of groundbreaking treatments The company collaborates with leading researchers and institutions to drive scientific progress and improve patient outcomes in the field of neuroscience
Founded Date:
2010
Last Funding Type:
Post-IPO Equity
Headquarters:
USA
Investors Number:
6
Technology:
P4 Medicine
Employee Number:
501-1000
Industry:
FemTech
Estimated Revenue:
$50M to $100M
Last Funding Date:
27 11 20
Number Of Exists:
Post-IPO Equity
Funding Status:
IPO
Investor Type:
Accelerators and Incubators
Investment Stage:
N/A
Total Funding:
1088000000